John F. Hannigan - Concepedia

Concepedia

Author

John F. Hannigan

Northern California Research

Also Known As

J F Hannigan, J Hannigan, J. Hannigan, J.F. Hannigan, John F. Hannigan, John Hannigan

32

Publications

2.4K

Citations

19

H-Index

54

Concepts

All Affiliations

Northern California Research University of California, San Francisco Stanford University Stanford Medicine Cancer Research Institute

JF

About

John F. Hannigan is an author at Northern California Research specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.9K
2	Health Sciences	4	4	673
3	Public Health	2	2	50
4	Allergy	1	1	58
5	Biostatistics	1	1	17

John F. Hannigan

×

23

Publications

2.4K

Citations

19

H-Index

	Year	Citations
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. David C. Hohn, Robert Stagg, Michael Friedman, Journal of Clinical Oncology Colorectal Cancer MetastaticHepatologyGastrointestinal OncologyIa FudrLiver Physiology	1989	453
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report Victor A. Levin, Pamela Silver, John F. Hannigan, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyPost-radiotherapy Adjuvant ChemotherapyOncologyRadiation TherapyMedicine	1990	399
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. W G Harker, Fredrick J. Meyers, Fuad S. Freiha, Journal of Clinical Oncology UrologyGenitourinary CancerUrinary TractMedian SurvivalMedicine	1985	353
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Frank M. Torti, Michael M. Bristow, Bert L. Lum, PubMed Myofibrillar LossHeart FailureCardiomyopathyCardiogenic ShockCardiovascular Disease	1986	199
Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. Frank H. Valone, Marc Friedman, Peter S. Wittlinger, Journal of Clinical Oncology Surgical OncologyCancer ManagementPharmacotherapyArm BOncology	1989	181
Hyperfractionated radiation therapy for brain-stem glioma: a Phase I–II trial William M. Wara, Raul C. Urtasun, Michael D. Prados, Journal of neurosurgery	1989	125
Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy Thomas Franz, Dawn A. Parsell, Roger M. Halualani, International Journal of Dermatology	1999	119
The Fate of the Bladder in Patients with Metastatic Bladder Cancer Treated with Cisplatin, Methotrexate and Vinblastine: A Northern California Oncology Group Study Frederick J. Meyers, John M. Palmer, Fuad S. Freiha, The Journal of Urology	1985	82
Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen David R. Gandara, Howard Wold, Edith A. Perez, JNCI Journal of the National Cancer Institute	1989	69
Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery Thomas J. Franz, Dawn A. Parsell, Judith Myers, International Journal of Dermatology Clobetasol PropionateAllergyCp FoamPlacebo SolutionClinical Dermatology	2000	58

Page 1